The Pulmonary Institute of the Tel Aviv Medical Center treats patients with pulmonary diseases using all diagnostic and treatment modalities of this field.
The Pulmonary Institute at Tel Aviv Sourasky Medical Center (Ichilov) is a national center of excellence for the diagnosis, treatment, and research of a wide range of pulmonary diseases. We combine multidisciplinary medical expertise, advanced technology, and innovative treatment approaches to provide our patients with the most precise and safe medical care.
The Institute's team, comprising leading specialists in pulmonary medicine, treats the full spectrum of lung diseases, from common conditions to complex and rare disorders. As a tertiary referral center, we receive complex cases from across Israel and offer diagnostic and treatment solutions that meet international standards.
Areas of Expertise and Services
Interventional Pulmonology: An advanced unit performing bronchoscopies and minimally invasive diagnostic and therapeutic procedures, often eliminating the need for complex surgery.
- Diagnosis and Treatment of Obstructive Lung Diseases: Advanced management of conditions such as severe asthma (including biological therapies) and chronic obstructive pulmonary disease (COPD).
- Lung Oncology: A fast-track pathway for early detection of lung cancer and multidisciplinary treatment in collaboration with the Oncology Division and Thoracic Surgery Department.
- Interstitial Lung Diseases (ILD): A dedicated clinic for the diagnosis and treatment of fibrotic lung diseases (pulmonary fibrosis).
- Pulmonary Hypertension: A specialized center for the treatment of this complex condition, using the latest medications and working closely with the Cardiology Division.
- Pulmonary Function Laboratory: An advanced laboratory offering a comprehensive range of pulmonary function tests and cardiopulmonary exercise testing (CPET).
As part of Tel Aviv Sourasky Medical Center, the Institute actively participates in international clinical trials. This commitment provides our patients with access to new medical technologies and investigational medications at the forefront of modern medicine, sometimes even before they are included in Israel's national health services basket.
Areas of Activity and Medical Units
The Pulmonary and Allergy Laboratory operates under the Laboratory Division and is staffed by a skilled and experienced professional team. The laboratory operates in accordance with Ministry of Health requirements, the ISO 9001:2015 standard, and Joint Commission International (JCI) standards.
Our services include a unique diagnostic service for assessing possible causal relationships between medical conditions and occupational exposure. The laboratory performs specialized, highly complex tests requiring qualified personnel, dedicated equipment, and specific reagents.
The laboratory provides services to departments, institutes, and clinics within the Medical Center, as well as other hospitals, health maintenance organizations (HMOs), independent clinics, and additional healthcare providers.
The laboratory maintains internal and external quality control programs. Internal quality control includes running control samples, documenting technical issues, investigating their causes, and implementing improvements. External quality assessment is conducted through proficiency testing programs provided by CAP and NEQAS.
Our vision is to ensure professional, reliable, efficient, and respectful laboratory services while meeting the needs and expectations of patients and healthcare providers. We also aim to serve as a specialized center for laboratory investigations related to environmental exposures.
The Pulmonary Clinic provides consultation, diagnostic evaluation, and follow-up care for patients referred by community pulmonologists, primary care physicians, or hospital departments following discharge.
The general clinic diagnoses and treats a wide range of pulmonary conditions, including:
-
Obstructive Lung Diseases: Asthma, chronic obstructive pulmonary disease (COPD), emphysema, and bronchiectasis.
-
Interstitial Lung Diseases: Diagnosis and treatment of conditions such as idiopathic pulmonary fibrosis (IPF), sarcoidosis, silicosis, and occupational lung diseases.
-
Evaluation of Suspicious Pulmonary Findings: Rapid assessment of pulmonary nodules, suspected thoracic tumors, and follow-up of incidental imaging findings.
-
Chronic Cough: Comprehensive evaluation of persistent or unexplained cough.
In addition to the general clinic, the Institute operates specialized clinics providing focused care by experts in specific pulmonary conditions:
-
Pulmonary Hypertension Clinic: Diagnosis and treatment of pulmonary vascular diseases, including invasive exercise testing.
-
Pulmonary Oncology Service: Specialized management of respiratory complications in patients with cancer.
-
Severe Asthma Clinic: Advanced and biological therapies for patients whose asthma remains uncontrolled despite conventional treatment.
-
Interstitial and Fibrotic Lung Disease (ILD) Clinic: Monitoring and treatment of fibrotic lung diseases, including antifibrotic medications.
The Pulmonary Day Care Unit provides a specialized medical service that bridges the gap between community-based outpatient care and inpatient hospital treatment.
The Unit offers urgent or complex medical care for patients with pulmonary conditions who require close monitoring and intravenous (parenteral) treatment but do not need overnight hospitalization.
Patients receive specialized treatment from Ichilov's pulmonary medicine experts and can return home after completing their treatment.
The Unit treats patients with:
-
Pulmonary Hypertension
-
Airway Diseases: Asthma and COPD
-
Pulmonary Oncology: Respiratory complications associated with lung cancer
-
Chronic Respiratory Infections: Bronchiectasis and cystic fibrosis (CF)
Services are provided by medical referral and prior appointment only.
The Pulmonary Physiology Unit provides diagnostic services for both outpatients and hospitalized patients.
The Unit performs pulmonary function tests as part of the medical evaluation of patients experiencing respiratory symptoms, such as shortness of breath, coughing, or difficulty breathing. These tests help physicians identify the underlying causes of symptoms and determine the most appropriate treatment.
The Unit offers advanced respiratory testing to support the diagnosis of pulmonary diseases, monitor treatment effectiveness, and assess lung function before surgery or other medical procedures.
The basic examination is spirometry, which measures lung volumes and airflow rates. In some cases, more advanced pulmonary function tests are required.
Main Purposes of Pulmonary Function Testing:
-
Diagnosing lung diseases in patients experiencing shortness of breath.
-
Monitoring the effectiveness of treatment for pulmonary diseases.
-
Assessing lung function before surgery.
-
Monitoring pulmonary function in patients taking medications that may affect lung function.
The Clinical Research Unit of the Pulmonary Institute operates at the forefront of medicine and science, combining clinical research, technological innovation, and basic research to advance the treatment of pulmonary diseases.
The Unit's research activities focus primarily on lung diseases, including asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, pulmonary fibrosis, and pulmonary hypertension.
We collaborate with leading pharmaceutical companies worldwide and participate in international clinical drug trials investigating innovative and groundbreaking treatments for various pulmonary diseases. As part of these activities, we enroll patients whose conditions remain uncontrolled despite currently available treatments, offering interested patients access to next-generation therapies under close medical supervision and in accordance with the highest standards of care.
Alongside clinical drug trials, the Unit conducts basic research aimed at understanding the biological mechanisms underlying pulmonary diseases. The Unit also leads investigator-initiated studies arising from the daily clinical practice of the Institute's physicians. These studies aim to improve treatment approaches, develop advanced models of care, and establish new medical services, translating research findings directly into clinical practice.
In addition, the Unit participates in artificial intelligence-based medical device studies in collaboration with Israeli startup companies, aiming to improve diagnosis, predict disease progression, and personalize treatment.
The Pulmonary Fibrosis Center of Excellence is a specialized multidisciplinary center dedicated to the diagnosis and treatment of patients with all types of pulmonary fibrosis.
Pulmonary fibrosis is a disease in which lung tissue becomes damaged and scarred, leading to breathing difficulties and reduced functional capacity. It is a relatively uncommon condition that requires accurate diagnosis and personalized treatment tailored to each patient's needs.
The Center is the largest of its kind in Israel and operates according to the standards of international centers of excellence.
Patients at the Pulmonary Fibrosis Center are offered the opportunity to participate in innovative clinical trials, depending on their medical condition and willingness to take part in research.
Shortness of breath (dyspnea) is a common and often distressing symptom. In some cases, its underlying cause remains unclear even after extensive medical testing. The clinic at Ichilov's Pulmonary Institute specializes in two main areas:
-
Treatment and Follow-Up of Patients with Pulmonary Hypertension: A condition affecting the blood vessels in the lungs and the right side of the heart.
-
Advanced Evaluation of Unexplained Dyspnea: Comprehensive diagnostic assessment for patients experiencing shortness of breath during physical exertion when the underlying cause has not yet been identified.
Pulmonary Hypertension
Pulmonary hypertension is a condition in which blood pressure increases in the blood vessels carrying blood from the heart to the lungs. This places excessive strain on the right side of the heart and may cause shortness of breath, fatigue, swelling (edema), and dizziness.
Pulmonary hypertension is classified into five main groups:
-
Pulmonary Arterial Hypertension (PAH): A rare condition in which the pulmonary arteries become narrowed and stiff. The disease may be hereditary, associated with connective tissue diseases (such as scleroderma), congenital, or have no known cause (idiopathic).
-
Pulmonary Hypertension Due to Left Heart Disease: The most common type. Impaired function of the left side of the heart causes pressure to build up and extend backward into the lungs.
-
Pulmonary Hypertension Due to Lung Diseases: Associated with conditions such as COPD, pulmonary fibrosis, or sleep apnea.
-
Chronic Thromboembolic Pulmonary Hypertension (CTEPH): A distinct condition caused by old blood clots that have not dissolved and obstruct the pulmonary blood vessels. Importantly, this type of pulmonary hypertension can potentially be completely cured through surgery or catheter-based intervention, making early diagnosis critical.
-
Pulmonary Hypertension Due to Other Causes: Including hematological disorders, metabolic diseases, and other rare conditions.
One of the greatest challenges in diagnosing shortness of breath is the close relationship between the heart and lungs. Patients often find themselves moving between specialists without receiving a clear diagnosis.
At Ichilov, we offer a unique model of care: a combined clinic where a pulmonologist and a cardiologist work together in real time. This collaboration enables a comprehensive assessment of both the cardiovascular and respiratory systems, shortens diagnostic times, prevents duplicate and unnecessary tests, and allows the development of a precise treatment plan that takes both systems into account.
The clinic's flagship diagnostic procedure is Invasive Cardiopulmonary Exercise Testing (Invasive CPET). This innovative, specialized test is designed for patients experiencing shortness of breath during physical exertion whose underlying condition cannot be identified through standard diagnostic tests.
The test combines cardiopulmonary exercise testing (cycling on a stationary bicycle) with right heart catheterization. Unlike conventional tests performed at rest, this procedure allows real-time measurements at peak exercise, including pressures and blood flow in the heart and lungs, oxygen utilization by the muscles, and additional physiological parameters.
The test is intended for patients who have undergone basic cardiac and pulmonary evaluations, such as echocardiography and pulmonary function testing, with normal results but who continue to experience functional limitations and shortness of breath.
Invasive CPET enables a highly accurate diagnosis, even in cases where other diagnostic tests have failed to identify the underlying cause.
The Airway Diseases Center provides specialized care for patients with complex chronic respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis.
The Center was established with the understanding that managing these conditions requires more than just an inhaler. We offer personalized medicine based on precise characterization of each patient's disease, with the aim of restoring their quality of life.
The service is intended for patients whose conditions remain uncontrolled despite treatment in community healthcare settings. Our approach brings together all necessary tests and specialists under one roof, saving valuable time and enabling faster diagnosis.
The Airway Diseases Center offers an advanced approach to the diagnosis and treatment of respiratory diseases through a One-Stop-Shop model, bringing together diagnostic tests and medical specialists in one location. This approach enables a rapid and accurate diagnostic process and the development of a personalized treatment plan for each patient.
The Center performs advanced laboratory tests to characterize the type of airway inflammation, FeNO testing to measure inflammation through a simple breath test, and pulmonary function tests and imaging studies as needed. In addition, the Center offers innovative biological therapies for patients with severe asthma, specifically targeting the underlying causes of inflammation.
Treatment at the Center is based on a multidisciplinary approach that includes respiratory physiotherapy, nutritional counseling, emotional support, and personalized guidance from a specialist nurse throughout the treatment process. This comprehensive approach aims to provide optimal care and improve patients' quality of life.
The Pulmonary Oncology Service, the first and only service of its kind in Israel, operates within the Pulmonary Institute.
The service specializes in the diagnosis and treatment of respiratory symptoms in patients with cancer, working in close collaboration with the Oncology Division and the Imaging Division at Ichilov.
In recent years, the use of advanced cancer treatments has increased significantly, including immunotherapy and other treatments that may cause lung tissue damage, such as radiation therapy and certain types of chemotherapy. This trend has been accompanied by an increase in the incidence of respiratory symptoms and complications.
Respiratory symptoms in these patients require a specialized and thorough evaluation due to the broad and complex range of possible underlying causes.
Some cases are attributed to lung injury resulting from cancer treatments, including pneumonitis, and require careful monitoring and treatment to ensure optimal management. Our primary goal is to preserve patients' future cancer treatment options while maintaining their quality of life.
Services provided by the clinic include:
-
Specialized pulmonary evaluation, diagnosis, and follow-up for cancer patients experiencing respiratory symptoms.
-
Development of personalized treatment plans in close collaboration with the Oncology Division.
-
Diagnosis, treatment, and follow-up of patients with pneumonitis.
-
Routine monitoring and follow-up before and during certain cancer treatments for patients at increased risk of respiratory side effects, patients with a history of respiratory complications related to cancer treatment, and patients with chronic lung diseases.
-
Pulmonary assessment before initiating treatments that may cause lung damage.
Interventional pulmonology is a subspecialty of pulmonary medicine that focuses on minimally invasive diagnostic and therapeutic procedures involving the airways, lung tissue, and pleura (the membranes surrounding the lungs).
These procedures are performed using advanced technologies, including flexible bronchoscopy, endobronchial ultrasound (EBUS), advanced navigation systems, and image-guided biopsies.
The aim is to diagnose and treat a wide range of pulmonary diseases while reducing the need for open surgical procedures and maintaining patient safety.